SMAD3 and neoplasm: SMAD family member 3 (SMAD3), a modulator of the neural lineage differentiation of pluripotent NSCs, served as a key regulator for the genetic promotion of the MNT, and its blockage reduced tumor innervation and tumor-related nociceptive behaviors in vivo [102,103].